武汉康蓝药业有限公司
Wuhan Calmland Pharmaceuticals Co. Ltd.
Country: CN CDE+DMF+CEP VERY_HIGH
🇨🇳 CDE
8
10 products shown
🇺🇸 DMF
7
7 products shown
🇪🇺 CEP
5
5 products shown
Total
20
registrations
🇨🇳 CDE 注册 (10)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Decitabine 地西他滨 | 2353-33-5 | Class A | Y20220001028 |
| Docetaxel 多西他赛 | 114977-28-5 | Class A | Y20230001145 |
| Docetaxel 多西他赛 | 114977-28-5 | Class I | Y20210000530 |
| Epinastine 盐酸依匹斯汀 | 80012-43-7 | Class A | Y20240000454 |
| Mitoxantrone 盐酸米托蒽醌 | 65271-80-9 | Class A | Y20190021168 |
| Nitrocaphane 硝卡芥 | 54940-95-3 | Class I | Y20240000706 |
| Paclitaxel 紫杉醇 | 33069-62-4 | Class A | Y20240000387 |
| Paclitaxel 紫杉醇 | 33069-62-4 | Class I | Y20220001032 |
| Pemetrexed Disodium 培美曲塞二钠 | 137281-23-3 | Class A | Y20220000308 |
| Tenofovir Alafenamide 富马酸丙酚替诺福韦 | 379270-37-8 | Class I | Y20240000289 |
🇺🇸 DMF 注册 (7)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| Decitabine 地西他滨 | 2353-33-5 | 32388 | 2017-12-08 |
| Docetaxel 多西他赛 | 114977-28-5 | 36878 | 2022-03-09 |
| Epinastine Hydrochloride 盐酸依匹斯汀 | 108929-04-0 | 40256 | 2024-08-07 |
| Paclitaxel 紫杉醇 | 33069-62-4 | 32512 | 2018-01-25 |
| Pemetrexed Disodium Hemipentahydrate 培美曲塞二钠 | 357166-30-4 | 31964 | 2017-07-27 |
| Pemetrexed Disodium Heptahydrate | 357166-29-1 | 31643 | 2017-03-31 |
| Tenofovir Alafenmide Fumarate | - | 40107 | 2024-06-21 |
🇪🇺 CEP 注册 (5)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Docetaxel 多西他赛 | 114977-28-5 | CEP 2022-011 - Rev 01 | 2026-01-16 |
| Epinastine Hydrochloride 盐酸依匹斯汀 | 108929-04-0 | CEP 2024-295 - Rev 00 | 2026-05-29 |
| Mitoxantrone Hydrochloride 盐酸米托蒽醌 | 70476-82-3 | CEP 2023-342 - Rev 00 | 2025-07-22 |
| Paclitaxel, Produced By A Semi-synthetic Process 中文：紫杉醇;英文/拉丁文：Paclitaxel | 33069-62-4 | CEP 2018-004 - Rev 02 | 2024-05-27 |
| Pemetrexed Disodium Heptahydrate | 357166-29-1 | CEP 2017-067 - Rev 02 | 2024-07-10 |
Source: cde+fda_direct; DMF高置信 | Updated: 2026-09-11 06:00:12